Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy.
Levites Y, Funk C, Wang X, Chakrabarty P, McFarland KN, Bramblett B, O'Neal V, Liu X, Ladd T, Robinson M, Allen M, Carrasquillo MM, Dickson D, Cruz P, Ryu D, Li HD, Price ND, Ertekin-Taner N, Golde TE.
Levites Y, et al. Among authors: price nd.
Mol Neurodegener. 2021 May 6;16(1):32. doi: 10.1186/s13024-021-00453-4.
Mol Neurodegener. 2021.
PMID: 33957936
Free PMC article.